IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Evaluate Safety and Biological Activity of ATYR1940 in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy (FSHD)
This study has been completed.
Sponsor:
aTyr Pharma, Inc.
Information provided by (Responsible Party):
aTyr Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT02603562
First received: November 5, 2015
Last updated: May 15, 2017
Last verified: May 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 14, 2017 |
| Primary Completion Date: | December 13, 2016 (Final data collection date for primary outcome measure) |